2014 PowerPoint Presentations
(A full screen PPT link can be found under the embedded PPT displays)2014-Jack-Mci-Latest
MCI 2014 Clifford Jack – The Relationship between A-beta Deposition, Neurodegeneration and Cognitive Function in Normal and Impaired Individuals
MCI 2014 Clifford Jack – The Relationship between A-beta Deposition, Neurodegeneration and Cognitive Function in Normal and Impaired Individuals
2014-Landau-MCI-2014-Final-Slides
MCI 2014 Susan Landau – Amyloid, Glucose Metabolism, and Longitudinal Change
MCI 2014 Susan Landau – Amyloid, Glucose Metabolism, and Longitudinal Change
2014-MCI-Talk-Park-Web-Final
2014 MCI Denise Park – Beta Amyloid Deposition in Very Healthy Adults: Risk Factors and Cognitive Consequences
2014 MCI Denise Park – Beta Amyloid Deposition in Very Healthy Adults: Risk Factors and Cognitive Consequences
202946566-MCI-Petersen-Miami-Final
MCI 2014 Ronald Petersen – The Role of Imaging Biomarkers in the Prediction of MCI and Dementia Due to AD
MCI 2014 Ronald Petersen – The Role of Imaging Biomarkers in the Prediction of MCI and Dementia Due to AD
2014-Chetelat-Mci-Slides
MCI 2014 Gael Chetalat – Variation in the Sequence of AD Biomarkers According to Brain Regions and Genetic Factors
MCI 2014 Gael Chetalat – Variation in the Sequence of AD Biomarkers According to Brain Regions and Genetic Factors
2014-Mormino-MCI-Symposium-Web-Final
MCI 2014 Elizabeth Mormino – Cognitive Correlates of Neurodegeneration Related to Beta-amyloid and Aging in Clinically Normal Individuals
MCI 2014 Elizabeth Mormino – Cognitive Correlates of Neurodegeneration Related to Beta-amyloid and Aging in Clinically Normal Individuals
2014-Wolk-Symposium-Final
MCI 2014 David Wolk – Clinical Implications of Concordant and Discordant Beta-Amyloid and Neurodegenerative Abnormalities in Mild Cognitive Impairment
MCI 2014 David Wolk – Clinical Implications of Concordant and Discordant Beta-Amyloid and Neurodegenerative Abnormalities in Mild Cognitive Impairment
2014-LoewensteinMCI-Jan16-2014
MCI 2014 David Loewenstein – Development of Novel Paradigms for Assessing and Monitoring Cognitive Change Across the MCI and PreMCI Spectrum
MCI 2014 David Loewenstein – Development of Novel Paradigms for Assessing and Monitoring Cognitive Change Across the MCI and PreMCI Spectrum
2014-Dodge-Symposium-MCI-2014-V7-Latest
MCI 2014 Hiroko Dodge – Biomarker Values Predictive of Cognitive Decline in MCI: Baseline or Progression?
MCI 2014 Hiroko Dodge – Biomarker Values Predictive of Cognitive Decline in MCI: Baseline or Progression?
2014-Schmand-2014-MCI-Slides
MCI 2014 Ben Schmand – On Cognitive Performance as the Endpoint in Clinical Trials
MCI 2014 Ben Schmand – On Cognitive Performance as the Endpoint in Clinical Trials
2014-Snitz-Symposium-Latest
MCI 2014 Beth Snitz – Cognitive Trajectories Associated with β-amyloid Deposition in Normal Aging and MCI
MCI 2014 Beth Snitz – Cognitive Trajectories Associated with β-amyloid Deposition in Normal Aging and MCI
2014-Schmand-2014-MCI-Slides
MCI 2014 Frederick Schmitt – Probability of Transition To and From MCI: Models of Clinical and Cognitive Features
MCI 2014 Frederick Schmitt – Probability of Transition To and From MCI: Models of Clinical and Cognitive Features
2014-Salloway-MCI-Miami-Keynote-1-14rev-latest
MCI 2014 Steven Salloway – Keynote Lecture: Challenges in the Diagnosis of Early Alzheimer’s Disease
MCI 2014 Steven Salloway – Keynote Lecture: Challenges in the Diagnosis of Early Alzheimer’s Disease
2014-Wolk-Symposium-Final
MCI 2014 David Wolk – Case 1: Clinical Implications of Discordant Biomarkers
MCI 2014 David Wolk – Case 1: Clinical Implications of Discordant Biomarkers
2014-Decarli-Mci-2014-Slides
MCI 2014 Charles DeCarli – Case 2: A Case of Vascular MCI
MCI 2014 Charles DeCarli – Case 2: A Case of Vascular MCI
2014-Scheltens-Mci-2014-Slides
MCI 2014 Philip Scheltens – Discrepancies between Amyloid PET and CSF in Dementia
MCI 2014 Philip Scheltens – Discrepancies between Amyloid PET and CSF in Dementia
2014-Rentz-MCI-2014-Symposium-Slides
MCI 2014 Dorene Rentz – Case 4: Longitudinal Cognitive and Imaging Changes in a 70 y/o woman with Initial Subjective Cognitive Concerns
MCI 2014 Dorene Rentz – Case 4: Longitudinal Cognitive and Imaging Changes in a 70 y/o woman with Initial Subjective Cognitive Concerns
2014-Benzinger-Mci-Case-Slides
MCI 2014 Tammie Benzinger – Case 5: When Amyloid Imaging isn’t Enough
MCI 2014 Tammie Benzinger – Case 5: When Amyloid Imaging isn’t Enough
2014-Fleisher-MCI-Amyloid-2014-latest
MCI 2014 Adam Fleisher – Case 6: Biomarker Use to Assist in Diagnosis of Atypical MCI Presentations/ Imaging for Identifying non-AD
MCI 2014 Adam Fleisher – Case 6: Biomarker Use to Assist in Diagnosis of Atypical MCI Presentations/ Imaging for Identifying non-AD
Wolk-Forum-Web-Final2014
MCI 2014 David Wolk – Incorporating Biomarkers of Amyloid and Neurogeneration in Clinical Evaluation of Mild Cognitive Impairment
MCI 2014 David Wolk – Incorporating Biomarkers of Amyloid and Neurogeneration in Clinical Evaluation of Mild Cognitive Impairment
Rentz-MCI-Public-Forum-Talk2014
MCI 2014 Dorene Rentz – The Role of Cognitive Reserve in the Clinical Presentation of Alzheimer’s Disease
MCI 2014 Dorene Rentz – The Role of Cognitive Reserve in the Clinical Presentation of Alzheimer’s Disease
2014-Public-Forum-Devous
MCI 2014 Michael Devous – Amyloid Imaging in Healthy Aging: Impact on Brain Function and Cognition
MCI 2014 Michael Devous – Amyloid Imaging in Healthy Aging: Impact on Brain Function and Cognition
2014-Salloway-MCI-Educational-Forum-
MCI 2014 Steven Salloway – Challenges in the Diagnosis of Early Alzheimer’s Disease
MCI 2014 Steven Salloway – Challenges in the Diagnosis of Early Alzheimer’s Disease
Fleisher-MCI-Amyloid-2014
Diagnosis of Mild Cognitive Impairment: Current Research and Clinical Utility
Diagnosis of Mild Cognitive Impairment: Current Research and Clinical Utility